Spots Global Cancer Trial Database for complete remission
Every month we try and update this database with for complete remission cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| FLYSYN in MRD Positive AML | NCT02789254 | Acute Myeloid L... | FLYSYN | 18 Years - | Synimmune GmbH | |
| Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse | NCT01794572 | Multiple Myelom... | Melphalan Autologous Hema... | 18 Years - 65 Years | Institut Cancerologie de l'Ouest | |
| Sulindac for Patients With AML | NCT01843179 | Acute Myeloid L... | Cytarabine Sulindac | 60 Years - | Massachusetts General Hospital | |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies | NCT01471067 | Blood And Marro... Leukemia Lymphoma Transplantation... Transplantation... | Melphalan Fludarabine Mycophenolate m... Tacrolimus Cord Blood Infu... Rituximab ATG Busulfan Clofarabine Total Body Irra... | 1 Year - 80 Years | M.D. Anderson Cancer Center | |
| Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients | NCT06180863 | Acute Myeloid L... | oral azacitidin... | 18 Years - 75 Years | Yale University | |
| Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer | NCT04743102 | Rectal Cancer Neoadjuvant The... Complete Remiss... Metastasis | multi-points an... traditional cCR | 18 Years - 80 Years | Beijing Chao Yang Hospital | |
| Sulindac for Patients With AML | NCT01843179 | Acute Myeloid L... | Cytarabine Sulindac | 60 Years - | Massachusetts General Hospital | |
| FLYSYN in MRD Positive AML | NCT02789254 | Acute Myeloid L... | FLYSYN | 18 Years - | Synimmune GmbH | |
| Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence. | NCT02907827 | Melanoma | follow up DW MR... | 18 Years - | Universitair Ziekenhuis Brussel | |
| Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2 | NCT04229979 | Acute Myeloid L... | Galinpepimut-S Azacitidine Venetoclax Decitabine Cytarabine Observation GM-CSF Montanide | 18 Years - | Sellas Life Sciences Group | |
| Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission | NCT01757535 | Leukemia, Myelo... | Oral Azacitidin... Placebo | 55 Years - | Celgene | |
| Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse | NCT01794572 | Multiple Myelom... | Melphalan Autologous Hema... | 18 Years - 65 Years | Institut Cancerologie de l'Ouest | |
| A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML | NCT03417427 | Leukemia, Myelo... | Decitabine and ... Ara-C | 14 Years - 60 Years | Nanfang Hospital, Southern Medical University | |
| Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission | NCT01757535 | Leukemia, Myelo... | Oral Azacitidin... Placebo | 55 Years - | Celgene | |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies | NCT01471067 | Blood And Marro... Leukemia Lymphoma Transplantation... Transplantation... | Melphalan Fludarabine Mycophenolate m... Tacrolimus Cord Blood Infu... Rituximab ATG Busulfan Clofarabine Total Body Irra... | 1 Year - 80 Years | M.D. Anderson Cancer Center | |
| Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML) | NCT00725283 | Leukaemia, Myel... | GSK Biologicals... | 18 Years - | GlaxoSmithKline | |
| Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse | NCT01794572 | Multiple Myelom... | Melphalan Autologous Hema... | 18 Years - 65 Years | Institut Cancerologie de l'Ouest | |
| Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients | NCT01934452 | Complete Remiss... | sunitinib sunitinib | 18 Years - 99 Years | Pfizer |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
